Another diet drug, Arena Pharmaceuticals’s Iorcaserin, appears to be in danger after a U.S. Food and Drug Administration advisory panel voted to reject it Thursday.
Continue reading FDA Panel Votes Against Aren…
Development of technologically advanced — and expensive — lifesaving treatments will continue to increase as the new health care reform law is phased in over the next few years.
Continue reading Technology an…
More than 43 million Americans were living in poverty in 2009, the largest number recorded in the 51 years of published estimates. One in five children are affected. The Census Bureau reports that the percentage of people witho…
It’s a busy day at the FDA today as panels meet to discuss two new drugs — one to help weight loss and the other to combat drug addiction — and decide whether to approve AstraZeneca’s new blood thinner medication.
…
Will doctors soon be consulting patients’ records on their Streaks? That is the plan, according to Dell Computers, which aims to load the tablet devices with health care software this fall. But it could be an uphill battle, as …